Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers

YoonJung Choi,1 HyeKyung Han,1 Dongseong Shin,2 Kyoung Soo Lim,3 Kyung-Sang Yu11Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 2Clinical Trials Center, Gachon University Gil Medical Center, Incheon, 3Department of Clinical Pha...

Full description

Bibliographic Details
Main Authors: Choi YJ, Han HK, Shin D, Lim KS, Yu KS
Format: Article
Language:English
Published: Dove Medical Press 2015-07-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/comparison-of-the-pharmacokinetics-and-tolerability-of-hcp1004-a-fixed-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/comparison-of-the-pharmacokinetics-and-tolerability-of-hcp1004-a-fixed-peer-reviewed-article-DDDT

Similar Items